TL;DR: Cellbyte is a Y Combinator Winter 2022 startup AI Agents for Pharma Drug Launches, currently active with a team of 3.
AI Agents for Pharma Drug Launches
Last verified:
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industry experience from his previous job at leading global Life Sciences consultancy Simon-Kucher. Felix has sold $3m+ ACV deals to customers like H&M for his previous YC startup. Samuel holds an MSc in Information Systems from TUM, and has built enterprise AI applications from scratch as ML Engineer at Celonis.
Built by LemStudio
Yes. Cellbyte was funded by Y Combinator in the Winter 2022 batch. AI Agents for Pharma Drug Launches
Cellbyte's AI agents help pharma companies launch new drugs worldwide. Market-leading firms are using Cellbyte to answer questions like “What price can we achieve for our new drug in the U.S. versus Germany?“. The three co-founders have known and worked with each other for many years: Daniel brings 5+ years of industr…
Cellbyte was part of Y Combinator's Winter 2022 batch.
Cellbyte has a team of 3 people according to Y Combinator's directory.
Cellbyte is currently listed as Active with a team of 3 in Y Combinator's directory.
Loading interactive view…